News
Lefamulin found noninferior to moxifloxacin for bacterial pneumonia
October 1, 2019
Oral lefamulin, the first pleuromutilin antibiotic approved for intravenous and oral administration, was noninferior to oral moxifloxacin for inducing an early clinical response in patients with bacterial pneumonia, acording to data from a global multicenter study of 738 individuals.
![1]()
News
Vitamin C infusion falls short for sepsis and ARDS patients
October 1, 2019
Vitamin C failed to improve organ dysfunction, inflammation, or vascular injury in adults with sepsis and ARDS.
![1]()
News
Hospital-acquired C. diff. tied to four ‘high-risk’ antibiotic classes
September 16, 2019
High-risk antibiotics included second-, third-, and fourth-generation cephalosporins, fluoroquinolones, carbapenems, and lincosamides.
![1]()
Article
Short Takes
September 12, 2019
In The Literature's Short Takes
![1]()
News
Health care–associated infection rates going down
September 6, 2019
Have targeted quality improvement measures led to an improvement in the prevalence of health care–associated infections (HAIs)?
![1]()
News
Some HCV medications associated with serious liver injury
August 29, 2019
In many cases, the medications should never have been prescribed, according to the FDA.
![1]()
Article
Use hospital MRSA rates to guide pediatric osteomyelitis treatment
August 28, 2019
SEATTLE – If your hospital MRSA rate is less than 10%, cefazolin is a reasonable empiric choice for acute pediatric hematogenous osteomyelitis.
![1]()
News
CPAP safety for infants with bronchiolitis on the general pediatrics floor
August 26, 2019
SEATTLE – “Very, very few” hospitals do bronchiolitis CPAP outside of the ICU.
![1]()
News
FUO, pneumonia often distinguishes influenza from RSV in hospitalized young children
August 22, 2019
LJUBLJANA, SLOVENIA – “These findings open new possibilities for antimicrobial stewardship in these groups of virally infected children.” Dr. Cihan Papan.
![1]()
News
FDA approves Xenleta for community-acquired bacterial pneumonia treatment
August 20, 2019
The approval was based on results from two trials with a total of 1,289 patients.
